Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Surprises Analysts Amid RD Progress WTFCN Q1 2026 Earnings EPS Exceeds Expectations by 613 Despite Flat Stock Reaction APEI Q1 2026 Earnings EPS Surges Past Estimates with 383 Beat ARM Q1 2026 Earnings EPS Beats Estimates Amid Strong Licensing Demand Altria Group MO Q1 2026 Earnings Earnings Beat Estimates Amidst Steady Operations Dyne Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Advances